Skip to search boxSkip to navigationSkip to main content

Cysteamine, a pro-BDNF drug, as an adjunctive treatment for schizophrenia

  • Peter F. Buckley(corresponding author)
    ,
  • Brian J. Miller
    ,
  • Anilkumar Pillai
    ,
  • Brian Kirkpatrick
*Corresponding author for this work
Scholary Output:
Contribution to journal
Letter
 Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Publication Information

Output type

Scholary Output:
Contribution to journal
Letter
 Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 268-269 (2 pages)

Journal (Volume, Issue Number)

Schizophrenia Research (Volume 158, Issue 1-3)

Publication milestones

  • Published - 2014

Publication status

Published - 2014

ISSN

0920-9964

Publication IDs

  • Scopus: 84906933819
  • PubMed: 25052781

Access to documents

Publication metrics

Metrics

Scopus
citations
4, opens in new tab
SciVal
FWCI
0.81
SciVal
Author count
4
SciVal
citations
3
SciVal
Paper percentile
46
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
1

PlumX, opens in new tab

Citation count
4
Captures
25
Social media
26

Funding Details

In the past 12 months, Dr. Miller has received grant/research support from the National Institute of Mental Health (NIMH), the American Psychiatric Association , and Georgia Regents University ; and honoraria from Medscape and Insight Consulting Group .
FundersFunding numbers
NIMH
-
APA
-
GRU
-